Voxsanity

Who may be able to join

Who might be able to join this trial:

You must have already completed a specific earlier study called "3133K1-3000" and had a brain scan (MRI) that confirmed a diagnosis of Alzheimer's disease
You must score 10 or higher on a standard memory and thinking test called the Mini-Mental Status Examination (MMSE) at the screening appointment
You must have a caregiver who is able to come with you to all clinic visits throughout the trial

Who may not be able to join:

You may not be eligible if you have any health or mental health condition, or any significant abnormal test result, that the study doctor believes would make it unsafe for you to participate or make it hard to measure how you respond to the treatment
You may not be eligible if your brain MRI scan shows any significant unusual findings or abnormalities
You may not be eligible if you have taken any experimental drugs or used any experimental medical devices (other than the drug bapineuzumab, which is being studied in this trial) in the 60 days before your screening appointment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status

Terminated

Phase

Phase 3

Sponsor

Pfizer

Registry

clinicaltrials_gov

Start date

1 December 2009

Est. completion

1 November 2012

Where this trial is recruiting

🇦🇺 Australia 🇧🇪 Belgium 🇨🇱 Chile 🇫🇮 Finland 🇫🇷 France 🇮🇹 Italy 🇯🇵 Japan 🇳🇱 Netherlands 🇳🇿 New Zealand 🇵🇱 Poland 🇵🇹 Portugal 🇸🇰 Slovakia 🇿🇦 South Africa 🇪🇸 Spain 🇸🇪 Sweden 🇨🇭 Switzerland 🇬🇧 United Kingdom

5 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Number of Participants Reporting a Serious Adverse Event.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov